The Dirty Little Secret About Marijuana Stocks They Don’t Tell You

Reality usually isn’t as great as the hype.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This article was originally published on Fool.com

Have you ever noticed that the food at a fast-food restaurant never looks as good as it does on the restaurant’s TV commercials? It’s not necessarily false advertising. Maybe some of those burgers really do sizzle, with moisture delicately falling off the crisp piece of lettuce.

Most of them don’t, though. But the fast-food restaurant has an incentive to portray its food in the most attractive light, so that’s exactly what it does.

The truth is that every company tries to present its products in the most attractive way possible. Marijuana growers such as Aurora CannabisCanopy Growth and Tilray certainly do. But the products these companies sell to investors isn’t actually cannabis. Instead, it’s growth.

There’s a dirty little secret that key players in the cannabis industry won’t tell you about the “products” they sell to investors: The growth they pitch isn’t as attractive as it might seem.

Woman with hand held up to her mouth next to a man with his hand held up to his ear

IMAGE SOURCE: GETTY IMAGES.

Near-term growth slower than you might think

Investors eagerly awaited the launch of the Canadian recreational marijuana market. Canada’s Parliamentary Budget Officer (PBO), which performs similar functions as the U.S. Congressional Budget Office, estimated that the Canadian marijuana market would be around $4 billion. The PBO’s range was $4.2 billion to $6.2 billion Canadian.

Will total revenue for Canada’s recreational marijuana market hit that level in 2019? Don’t count on it. Arcview Market Research and BDS Analytics project that legal cannabis spending in Canada will total closer to $2.7 billion next year.

The reality is that it takes time for a new market to ramp up. Colorado’s recreational marijuana market provides a good case in point. So does California, which saw lower initial sales than expected with the launch of its recreational marijuana market this year.

We’re already seeing product shortages in Canada. The country’s provinces are still working out the kinks in their processes. Aphria CEO Vic Neufeld warned there could be significant problems even before Canada’s recreational market opened. His predictions appear to be coming true.

Remember, too, that marijuana growers are still not anywhere close to their projected production capacities. Aurora Cannabis, for example, talks about funded annual capacity of more than 500,000 kilograms. Right now, though, the company’s actual capacity is a lot closer to 50,000 kilograms per year. 

The huge market opportunity is way in the future

Most of the big Canadian marijuana growers don’t focus just on the Canadian market, though. They’re fully aware that their companies’ market caps can’t be justified based on the domestic opportunity.

That’s why Tilray CEO Brendan Kennedy went on CNBC a couple of months ago playing up the $150 billion global cannabis industry and the possibility for multiple marijuana companies with $100 billion valuations. It’s why Canopy Growth founder and co-CEO Bruce Linton appeared on CNBC as well talking about how cannabis could disrupt a $500 billion global market.

Were these executives plucking numbers out of the air? No. A United Nations report has stated that the global marijuana market totals around $150 billion. If you include alcohol, cigarettes, and pharmaceuticals markets that could potentially be disrupted by cannabis, a figure of $500 billion isn’t unrealistic.

But will Aurora, Canopy, Tilray, and others compete in a $150 billion market in the next five years? No. How about 10 years from now? It’s still only a maybe.

That $150 billion U.N. statistic includes illegal sales of recreational marijuana. To get to a legal market of that size would require a whole lot of countries to legalize recreational weed. So far, the grand total of countries to do so is two — Canada and Uruguay. 

Mexico could be added to the list soon. The country’s Supreme Court recently overturned a ban on recreational marijuana. However, there’s no guarantee that Mexico will legalize the sale of recreational marijuana. It could simply allow the legal use of the drug.

The bottom line is that the long-term growth that marijuana executives would like for you to focus on is likely way in the future. While the global cannabis industry will certainly expand over the next five years, it won’t come anywhere close to the level of growth you might envision based on public comments from some CEOs.

What’s an investor to do?

Paying a premium for a big marijuana stock like Aurora, Canopy, or Tilray could be fine for investors with a lot of patience. If the global marijuana market increases to anywhere close to $150 billion, all three of these companies should be worth a lot more than they are now.

Another alternative is to focus on smaller marijuana stocks with less lofty valuations that have better realistic prospects for growth over the next three to five years. Origin House appears to fit the bill, for example.

The company is the largest cannabis distributor in California. Origin House’s market cap currently stands at around $500 million. With the California market projected to more than double by 2022 and opportunities for the company to add more brands to its lineup, Origin House should be able to generate annual revenue of around $325 million by 2020 and even higher after then.

Regardless of which path you take, understand the reality of growth prospects for the stocks you buy. And know that those burgers you see on TV probably won’t be what you get in the drive-through, either.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Keith Speights has no position in any of the stocks mentioned. The Motley Fool US recommends Origin House. The Motley Fool has a disclosure policy.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »